Haploidentical hematopoietic stem cell transplant for patients with sickle cell disease using thiotepa, fludarabine, thymoglobulin, low dose cyclophosphamide, 200 cGy tbi and post transplant cyclophosphamide

Bone Marrow Transplant. 2018 May;53(5):647-650. doi: 10.1038/s41409-017-0077-1. Epub 2018 Jan 16.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Anemia, Sickle Cell / therapy*
  • Antilymphocyte Serum / therapeutic use
  • Child
  • Cyclophosphamide / therapeutic use
  • Female
  • Hematopoietic Stem Cell Transplantation / methods*
  • Humans
  • Male
  • Thiotepa / therapeutic use
  • Transplantation Conditioning / methods*
  • Transplantation, Haploidentical
  • Vidarabine / analogs & derivatives
  • Vidarabine / therapeutic use
  • Whole-Body Irradiation / methods
  • Young Adult

Substances

  • Antilymphocyte Serum
  • Cyclophosphamide
  • Thiotepa
  • thymoglobulin
  • Vidarabine
  • fludarabine